Given the central role of AIM2 inflammasome in inflammatory pathologies, M2exo@HMPB—a biomimetic mineralization inhibitor—holds therapeutic potential beyond VaD, including neurodegenerative and autoimmune diseases. The gene discussed is AIM2; the disease is autoimmune disease.